Biologics Production in Global Demand
Biologics are one key growth driver in pharmaceutical and biotechnology industries. The global market for biologics or biotechnology drugs increased to $87 billion in 2008. By 2010, the global annual sales of biologics will have increased by $26 billion, compared to a $13 billion increase for small molecules. A booming necessity for biologics in the drug market is driving the global demand for biologics manufacturing capacity.
Antagen Technology — Protein Expression System
Antagen has pioneered the biologics production through its innovative fast-track and high-efficiency protein expression system. The expression system not only shortens the development time of stable cell lines to 2-3 months from traditional 6-12 months, but also increases the expression yield of target proteins more than two dozenfold.